Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-09-000066
Filing Date
2009-01-06
Accepted
2009-01-06 15:08:50
Documents
1
Period of Report
2009-01-02

Document Format Files

Seq Description Document Type Size
1 c56234_ex.html 4  
1 c56234_ex.xml 4 3950
  Complete submission text file 0000930413-09-000066.txt   6047
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 865 S W 75TH AVENUE SUITE 100 PLANTATION FL 33324 9542338746
SALISBURY ROBERT C (Reporting) CIK: 0001185468 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 09509696